RespireRx Pharmaceuticals Inc (RSPI)

[eawolfie]

So this is an ongoing issue with all biotechs. If the stock is way down, is it automatically the fault of management or is it simply problems with the drug in development? Management can be blamed for poorly designed trials, bad business judgment in deal making or raising funds and the ill considered waste of funds on hand. In the end though, the drug has to go through testing. Testing means that the company thinks they have a pathway for a successful drug but the outcome has no guarantees. No one knows exactly either the best framework for testing or whether the drug will actually work in the designed setting. Development is an educated art. There is a large factor of the unforeseen in the act. the people who defend management likely think that the main reason for the stock decline lies in development problems that could not be anticipated. If one thinks otherwise, that management issues are to blame and not the science, then perhaps the investor feels more frustrated and less to blame for the poor investment. It also makes it harder to give up on the company if you still believe that success is achievable. That has to be the reason that you have maintained your investment for eight years. Your education is fine and your frustration is understandable.